Edwards Lifesciences Long-Term Investments 2010-2025 | EW
Edwards Lifesciences long-term investments from 2010 to 2025. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
- Edwards Lifesciences long-term investments for the quarter ending March 31, 2025 were $0.308B, a 47.27% decline year-over-year.
- Edwards Lifesciences long-term investments for 2024 were $0.308B, a 47.27% decline from 2023.
- Edwards Lifesciences long-term investments for 2023 were $0.584B, a 52.87% decline from 2022.
- Edwards Lifesciences long-term investments for 2022 were $1.239B, a 32.45% decline from 2021.
| Edwards Lifesciences Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024 | $308 |
| 2023 | $584 |
| 2022 | $1,239 |
| 2021 | $1,834 |
| 2020 | $802 |
| 2019 | $586 |
| 2018 | $0 |
| 2017 | $567 |
| 2016 | $532 |
| 2015 | $380 |
| 2014 | $241 |
| 2013 | $22 |
| 2012 | $21 |
| 2011 | $22 |
| 2010 | $25 |
| 2009 | $22 |
| Edwards Lifesciences Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-12-31 | $308 |
| 2024-09-30 | $320 |
| 2024-06-30 | $353 |
| 2024-03-31 | $456 |
| 2023-12-31 | $584 |
| 2023-09-30 | $705 |
| 2023-06-30 | $856 |
| 2023-03-31 | $1,067 |
| 2022-12-31 | $1,239 |
| 2022-09-30 | $1,381 |
| 2022-06-30 | $1,491 |
| 2022-03-31 | $1,624 |
| 2021-12-31 | $1,834 |
| 2021-09-30 | $1,282 |
| 2021-06-30 | $1,014 |
| 2021-03-31 | $802 |
| 2020-12-31 | $802 |
| 2020-09-30 | $599 |
| 2020-06-30 | $594 |
| 2020-03-31 | $588 |
| 2019-12-31 | $586 |
| 2019-09-30 | $386 |
| 2019-06-30 | $413 |
| 2019-03-31 | $454 |
| 2018-12-31 | |
| 2018-09-30 | $479 |
| 2018-06-30 | $470 |
| 2018-03-31 | $532 |
| 2017-12-31 | $567 |
| 2017-09-30 | $568 |
| 2017-06-30 | $552 |
| 2017-03-31 | $519 |
| 2016-12-31 | $532 |
| 2016-09-30 | $468 |
| 2016-06-30 | $392 |
| 2016-03-31 | $369 |
| 2015-12-31 | $380 |
| 2015-09-30 | $366 |
| 2015-06-30 | $325 |
| 2015-03-31 | $256 |
| 2014-12-31 | $241 |
| 2014-09-30 | $92 |
| 2014-06-30 | $99 |
| 2014-03-31 | $95 |
| 2013-12-31 | $22 |
| 2013-09-30 | $21 |
| 2013-06-30 | $22 |
| 2013-03-31 | $23 |
| 2012-12-31 | $21 |
| 2012-09-30 | $23 |
| 2012-06-30 | $22 |
| 2012-03-31 | $22 |
| 2011-12-31 | $22 |
| 2011-09-30 | $21 |
| 2011-06-30 | $25 |
| 2011-03-31 | $27 |
| 2010-12-31 | $25 |
| 2010-09-30 | $22 |
| 2010-06-30 | $22 |
| 2010-03-31 | $22 |
| 2009-12-31 | $22 |
| 2009-09-30 | $25 |
| 2009-06-30 | $20 |
| 2009-03-31 | $17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $43.878B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $201.227B | 88.14 |
| Thermo Fisher Scientific (TMO) | United States | $163.300B | 19.75 |
| Alcon (ALC) | Switzerland | $46.755B | 31.08 |
| IDEXX Laboratories (IDXX) | United States | $40.977B | 47.09 |
| DexCom (DXCM) | United States | $33.349B | 51.54 |
| IQVIA Holdings (IQV) | United States | $27.010B | 15.13 |
| Mettler-Toledo (MTD) | United States | $24.411B | 29.03 |
| STERIS (STE) | Ireland | $22.902B | 26.19 |
| Waters (WAT) | United States | $21.820B | 30.79 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.782B | 0.00 |
| Hologic (HOLX) | United States | $13.106B | 14.24 |
| Penumbra (PEN) | United States | $11.523B | 90.44 |
| Sysmex ADR (SSMXY) | Japan | $11.349B | 0.00 |
| Masimo (MASI) | United States | $8.868B | 32.71 |
| Globus Medical (GMED) | United States | $8.116B | 19.03 |
| Teleflex (TFX) | United States | $5.711B | 9.43 |
| Glaukos (GKOS) | United States | $5.408B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.211B | 22.07 |
| TransMedics (TMDX) | United States | $4.016B | 87.30 |
| PROCEPT BioRobotics (PRCT) | United States | $3.012B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.466B | 14.69 |
| Veracyte (VCYT) | United States | $2.409B | 33.80 |
| Nihon Kohden (NHNKY) | Japan | $2.072B | 11.33 |
| Elekta AB (EKTAY) | Sweden | $1.983B | 17.83 |
| Alphatec Holdings (ATEC) | United States | $1.852B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.562B | 0.00 |
| Artivion (AORT) | United States | $1.229B | 115.08 |
| Pulse Biosciences (PLSE) | United States | $1.130B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.062B | 5.65 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| SiBone (SIBN) | United States | $0.800B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.696B | 15.20 |
| IRadimed (IRMD) | United States | $0.668B | 33.92 |
| Beta Bionics (BBNX) | United States | $0.615B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| OrthoPediatrics (KIDS) | United States | $0.565B | 0.00 |
| RxSight (RXST) | United States | $0.559B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.503B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.485B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.452B | 0.00 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.382B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.334B | 7.10 |
| Pacific Biosciences Of California (PACB) | United States | $0.330B | 0.00 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.226B | 13.69 |
| 908 Devices (MASS) | United States | $0.205B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.197B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.166B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.163B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.126B | 0.00 |
| CVRx (CVRX) | United States | $0.124B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.116B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.080B | 0.00 |
| InspireMD (NSPR) | Israel | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.075B | 11.38 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.050B | 15.25 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |